GB795174A - Heterocyclic sulphonamides - Google Patents
Heterocyclic sulphonamidesInfo
- Publication number
- GB795174A GB795174A GB27101/55A GB2710155A GB795174A GB 795174 A GB795174 A GB 795174A GB 27101/55 A GB27101/55 A GB 27101/55A GB 2710155 A GB2710155 A GB 2710155A GB 795174 A GB795174 A GB 795174A
- Authority
- GB
- United Kingdom
- Prior art keywords
- sulphenamide
- sulphonamides
- thiadiazole
- heterocyclic
- sulphonamide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- -1 Heterocyclic sulphonamides Chemical class 0.000 title abstract 6
- 125000000623 heterocyclic group Chemical group 0.000 abstract 7
- RWRDLPDLKQPQOW-UHFFFAOYSA-N Pyrrolidine Chemical compound C1CCNC1 RWRDLPDLKQPQOW-UHFFFAOYSA-N 0.000 abstract 6
- 150000003456 sulfonamides Chemical class 0.000 abstract 5
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 abstract 4
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 abstract 4
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 abstract 4
- 230000003647 oxidation Effects 0.000 abstract 4
- 238000007254 oxidation reaction Methods 0.000 abstract 4
- FDDDEECHVMSUSB-UHFFFAOYSA-N sulfanilamide Chemical compound NC1=CC=C(S(N)(=O)=O)C=C1 FDDDEECHVMSUSB-UHFFFAOYSA-N 0.000 abstract 4
- 229940124530 sulfonamide Drugs 0.000 abstract 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 abstract 3
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 abstract 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 abstract 3
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 abstract 3
- 238000004073 vulcanization Methods 0.000 abstract 3
- KDCGOANMDULRCW-UHFFFAOYSA-N 7H-purine Chemical compound N1=CNC2=NC=NC2=C1 KDCGOANMDULRCW-UHFFFAOYSA-N 0.000 abstract 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 abstract 2
- YLQBMQCUIZJEEH-UHFFFAOYSA-N Furan Chemical compound C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 abstract 2
- YNAVUWVOSKDBBP-UHFFFAOYSA-N Morpholine Chemical group C1COCCN1 YNAVUWVOSKDBBP-UHFFFAOYSA-N 0.000 abstract 2
- PXXGHYLXDVMQRG-UHFFFAOYSA-N N-(2-aminosulfanyl-1,3-benzothiazol-6-yl)acetamide Chemical compound C(C)(=O)NC1=CC2=C(N=C(S2)SN)C=C1 PXXGHYLXDVMQRG-UHFFFAOYSA-N 0.000 abstract 2
- GLUUGHFHXGJENI-UHFFFAOYSA-N Piperazine Chemical group C1CNCCN1 GLUUGHFHXGJENI-UHFFFAOYSA-N 0.000 abstract 2
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical group C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 abstract 2
- KYQCOXFCLRTKLS-UHFFFAOYSA-N Pyrazine Chemical compound C1=CN=CC=N1 KYQCOXFCLRTKLS-UHFFFAOYSA-N 0.000 abstract 2
- KAESVJOAVNADME-UHFFFAOYSA-N Pyrrole Chemical compound C=1C=CNC=1 KAESVJOAVNADME-UHFFFAOYSA-N 0.000 abstract 2
- SMWDFEZZVXVKRB-UHFFFAOYSA-N Quinoline Chemical compound N1=CC=CC2=CC=CC=C21 SMWDFEZZVXVKRB-UHFFFAOYSA-N 0.000 abstract 2
- YTPLMLYBLZKORZ-UHFFFAOYSA-N Thiophene Chemical compound C=1C=CSC=1 YTPLMLYBLZKORZ-UHFFFAOYSA-N 0.000 abstract 2
- 239000002253 acid Substances 0.000 abstract 2
- 125000000217 alkyl group Chemical group 0.000 abstract 2
- 229910021529 ammonia Inorganic materials 0.000 abstract 2
- 125000003118 aryl group Chemical group 0.000 abstract 2
- 125000004432 carbon atom Chemical group C* 0.000 abstract 2
- 238000009833 condensation Methods 0.000 abstract 2
- 230000005494 condensation Effects 0.000 abstract 2
- 229910052736 halogen Inorganic materials 0.000 abstract 2
- 150000002367 halogens Chemical class 0.000 abstract 2
- 125000005842 heteroatom Chemical group 0.000 abstract 2
- 238000000034 method Methods 0.000 abstract 2
- 230000001590 oxidative effect Effects 0.000 abstract 2
- 238000002360 preparation method Methods 0.000 abstract 2
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 abstract 2
- GHWHFERRHRDJER-UHFFFAOYSA-N s-(6-ethoxy-1,3-benzothiazol-2-yl)thiohydroxylamine Chemical compound CCOC1=CC=C2N=C(SN)SC2=C1 GHWHFERRHRDJER-UHFFFAOYSA-N 0.000 abstract 2
- 239000000243 solution Substances 0.000 abstract 2
- 239000002904 solvent Substances 0.000 abstract 2
- MJUFRJHCTYRNEW-UHFFFAOYSA-N (6-acetamidopyrimidin-4-yl) acetate Chemical compound C(C)(=O)NC1=CC(=NC=N1)OC(C)=O MJUFRJHCTYRNEW-UHFFFAOYSA-N 0.000 abstract 1
- BCMCBBGGLRIHSE-UHFFFAOYSA-N 1,3-benzoxazole Chemical compound C1=CC=C2OC=NC2=C1 BCMCBBGGLRIHSE-UHFFFAOYSA-N 0.000 abstract 1
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 abstract 1
- HYZJCKYKOHLVJF-UHFFFAOYSA-N 1H-benzimidazole Chemical compound C1=CC=C2NC=NC2=C1 HYZJCKYKOHLVJF-UHFFFAOYSA-N 0.000 abstract 1
- MGADZUXDNSDTHW-UHFFFAOYSA-N 2H-pyran Chemical compound C1OC=CC=C1 MGADZUXDNSDTHW-UHFFFAOYSA-N 0.000 abstract 1
- BCHZICNRHXRCHY-UHFFFAOYSA-N 2h-oxazine Chemical compound N1OC=CC=C1 BCHZICNRHXRCHY-UHFFFAOYSA-N 0.000 abstract 1
- AGIJRRREJXSQJR-UHFFFAOYSA-N 2h-thiazine Chemical compound N1SC=CC=C1 AGIJRRREJXSQJR-UHFFFAOYSA-N 0.000 abstract 1
- WEQPBCSPRXFQQS-UHFFFAOYSA-N 4,5-dihydro-1,2-oxazole Chemical compound C1CC=NO1 WEQPBCSPRXFQQS-UHFFFAOYSA-N 0.000 abstract 1
- YFYYRKDBDBILSD-UHFFFAOYSA-N 6-amino-2-sulfanylidene-1h-pyrimidin-4-one Chemical compound NC1=CC(=O)NC(=S)N1 YFYYRKDBDBILSD-UHFFFAOYSA-N 0.000 abstract 1
- HOASVNMVYBSLSU-UHFFFAOYSA-N 6-ethoxy-3h-1,3-benzothiazole-2-thione Chemical compound CCOC1=CC=C2N=C(S)SC2=C1 HOASVNMVYBSLSU-UHFFFAOYSA-N 0.000 abstract 1
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 abstract 1
- QDHHCQZDFGDHMP-UHFFFAOYSA-N Chloramine Chemical compound ClN QDHHCQZDFGDHMP-UHFFFAOYSA-N 0.000 abstract 1
- SLLUWNOHIGQACM-UHFFFAOYSA-N N-(2-aminosulfanyl-6-oxo-1H-pyrimidin-4-yl)acetamide Chemical compound C(C)(=O)NC1=CC(=NC(=N1)SN)O SLLUWNOHIGQACM-UHFFFAOYSA-N 0.000 abstract 1
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 abstract 1
- NNDHCURZZWRJGJ-UHFFFAOYSA-N O=S(=O)NCCC1=CC=CC=C1 Chemical class O=S(=O)NCCC1=CC=CC=C1 NNDHCURZZWRJGJ-UHFFFAOYSA-N 0.000 abstract 1
- ZCQWOFVYLHDMMC-UHFFFAOYSA-N Oxazole Chemical compound C1=COC=N1 ZCQWOFVYLHDMMC-UHFFFAOYSA-N 0.000 abstract 1
- PCNDJXKNXGMECE-UHFFFAOYSA-N Phenazine Natural products C1=CC=CC2=NC3=CC=CC=C3N=C21 PCNDJXKNXGMECE-UHFFFAOYSA-N 0.000 abstract 1
- CZPWVGJYEJSRLH-UHFFFAOYSA-N Pyrimidine Chemical compound C1=CN=CN=C1 CZPWVGJYEJSRLH-UHFFFAOYSA-N 0.000 abstract 1
- 239000005708 Sodium hypochlorite Substances 0.000 abstract 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical group [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 abstract 1
- FZWLAAWBMGSTSO-UHFFFAOYSA-N Thiazole Chemical compound C1=CSC=N1 FZWLAAWBMGSTSO-UHFFFAOYSA-N 0.000 abstract 1
- 230000001476 alcoholic effect Effects 0.000 abstract 1
- 239000012670 alkaline solution Substances 0.000 abstract 1
- 125000003545 alkoxy group Chemical group 0.000 abstract 1
- 125000003368 amide group Chemical group 0.000 abstract 1
- 239000000908 ammonium hydroxide Substances 0.000 abstract 1
- 125000003710 aryl alkyl group Chemical group 0.000 abstract 1
- KXNQKOAQSGJCQU-UHFFFAOYSA-N benzo[e][1,3]benzothiazole Chemical compound C1=CC=C2C(N=CS3)=C3C=CC2=C1 KXNQKOAQSGJCQU-UHFFFAOYSA-N 0.000 abstract 1
- 229910052799 carbon Inorganic materials 0.000 abstract 1
- 125000005518 carboxamido group Chemical group 0.000 abstract 1
- KRVSOGSZCMJSLX-UHFFFAOYSA-L chromic acid Substances O[Cr](O)(=O)=O KRVSOGSZCMJSLX-UHFFFAOYSA-L 0.000 abstract 1
- 238000013329 compounding Methods 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 150000004662 dithiols Chemical class 0.000 abstract 1
- OUZWUKMCLIBBOG-UHFFFAOYSA-N ethoxzolamide Chemical compound CCOC1=CC=C2N=C(S(N)(=O)=O)SC2=C1 OUZWUKMCLIBBOG-UHFFFAOYSA-N 0.000 abstract 1
- AWJWCTOOIBYHON-UHFFFAOYSA-N furo[3,4-b]pyrazine-5,7-dione Chemical compound C1=CN=C2C(=O)OC(=O)C2=N1 AWJWCTOOIBYHON-UHFFFAOYSA-N 0.000 abstract 1
- CTAPFRYPJLPFDF-UHFFFAOYSA-N isoxazole Chemical compound C=1C=NOC=1 CTAPFRYPJLPFDF-UHFFFAOYSA-N 0.000 abstract 1
- 230000004048 modification Effects 0.000 abstract 1
- 238000012986 modification Methods 0.000 abstract 1
- 229910017604 nitric acid Inorganic materials 0.000 abstract 1
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 abstract 1
- 239000007800 oxidant agent Substances 0.000 abstract 1
- 239000012286 potassium permanganate Substances 0.000 abstract 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 1
- CPNGPNLZQNNVQM-UHFFFAOYSA-N pteridine Chemical compound N1=CN=CC2=NC=CN=C21 CPNGPNLZQNNVQM-UHFFFAOYSA-N 0.000 abstract 1
- PBMFSQRYOILNGV-UHFFFAOYSA-N pyridazine Chemical compound C1=CC=NN=C1 PBMFSQRYOILNGV-UHFFFAOYSA-N 0.000 abstract 1
- UDJFFSGCRRMVFH-UHFFFAOYSA-N pyrido[2,3-d]pyrimidine Chemical compound N1=CN=CC2=CC=CN=C21 UDJFFSGCRRMVFH-UHFFFAOYSA-N 0.000 abstract 1
- 150000003335 secondary amines Chemical class 0.000 abstract 1
- SUKJFIGYRHOWBL-UHFFFAOYSA-N sodium hypochlorite Chemical compound [Na+].Cl[O-] SUKJFIGYRHOWBL-UHFFFAOYSA-N 0.000 abstract 1
- PFUVRDFDKPNGAV-UHFFFAOYSA-N sodium peroxide Chemical compound [Na+].[Na+].[O-][O-] PFUVRDFDKPNGAV-UHFFFAOYSA-N 0.000 abstract 1
- 125000000565 sulfonamide group Chemical group 0.000 abstract 1
- 150000003536 tetrazoles Chemical class 0.000 abstract 1
- 150000003573 thiols Chemical class 0.000 abstract 1
- 229930192474 thiophene Natural products 0.000 abstract 1
- 150000003852 triazoles Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/56—One oxygen atom and one sulfur atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
- C07D277/62—Benzothiazoles
- C07D277/68—Benzothiazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
- C07D277/70—Sulfur atoms
- C07D277/76—Sulfur atoms attached to a second hetero atom
- C07D277/80—Sulfur atoms attached to a second hetero atom to a nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
- C07D285/01—Five-membered rings
- C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
- C07D285/04—Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
- C07D285/12—1,3,4-Thiadiazoles; Hydrogenated 1,3,4-thiadiazoles
- C07D285/125—1,3,4-Thiadiazoles; Hydrogenated 1,3,4-thiadiazoles with oxygen, sulfur or nitrogen atoms, directly attached to ring carbon atoms, the nitrogen atoms not forming part of a nitro radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
- C07D285/01—Five-membered rings
- C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
- C07D285/04—Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
- C07D285/12—1,3,4-Thiadiazoles; Hydrogenated 1,3,4-thiadiazoles
- C07D285/125—1,3,4-Thiadiazoles; Hydrogenated 1,3,4-thiadiazoles with oxygen, sulfur or nitrogen atoms, directly attached to ring carbon atoms, the nitrogen atoms not forming part of a nitro radical
- C07D285/135—Nitrogen atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Lubricants (AREA)
- Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
The invention comprises C-polyheterocyclic sulphonamides, i.e those containing 2 or more hetero atoms in the heterocycle, containing a sulphur atom in the alpha position to the sulphonamide group and/or having the heterocycle at least partly reduced; compounds of the formula R-SO2NR1R11 wherein -NR1R11 is a primary, secondary or tertiary amido group and R is a partially or wholly reduced thiazole, oxazole, imidazole, pyrimidine, pyrazine, pyridazine, oxazine, thiazine or thiadiazole radical; 6-ethoxybenzothiazole-2-sulphonamide; 4-phenyl-5-thiono-4 : 5-dihydro-1 : 3 : 4 - thiadiazole - 2 - sulphonamide; 6 - carboxamidobenzothiazole - 2 - sulphonamides and 6 - carboxamido - 4 - hydroxy - pyrimidine-2-sulphonamides containing from 1 to 8 carbon atoms in the carboxamido radical; and the preparation of C-heterocyclic sulphonamides in general by the oxidative condensation of a C-heterocyclic thiol and ammonia or a primary or secondary amine followed by oxidation of the resulting sulphenamide. In a modification of this process the sulphenamide is prepared by reacting a C-heterocyclic thiol with an N-chloramine. Preferably, the oxidative condensation is brought about with the aid of a hypohalite or a halogen in aqueous alkaline solution, with addition of a water-miscible solvent, e.g. ethanol or dioxan, if necessary, the temperature preferably being kept below 30 DEG C. and advantageously at 0 DEG to 10 DEG C. Acid oxidation or a two-stage process via the disulphide may also be used. The oxidation of the sulphenamides to the sulphonamides is advantageously achieved with aqueous potassium permanganate in a suitable solvent, although other oxidizing agents such as alkaline hydrogen peroxide and sodium peroxide, hydrogen peroxide in acetic acid, chromic acid, nitric acid or permanganic acid can also be used, at temperatures normally between 0 DEG and 50 DEG C. In examples: (1) 6-ethoxybenzothiazole-2-thiol in sodium hydroxide solution reacts with sodium hypochlorite solution and ammonium hydroxide at a low temperature to give 6-ethoxybenzothiazole-2-sulphenamide which on permanganate oxidation gives the corresponding sulphonamide; (2) 6-acetamidobenzothiazole-2-sulphenamide, the corresponding 4- and 6-propionamido-, 4- and 6-valeramido-, 4- and 6-caprylamido-, 4- and 6-benzamido- and 4-carboxy-6-benzamido-compounds, and the sulphonamides corresponding to all these sulphenamides are similarly prepared; (3) 4-phenyl-5-thiono-4 : 5-dihydro-1 : 3 : 4-thiadiazole-2-sulphenamide is prepared either as in (1) or by treating the corresponding disulphide with alcoholic ammonia and is then oxidized as in (1) to the corresponding sulphonamide; 4 : 4 : 6-trimethyl-1 : 2 : 3 : 4-tetrahydropyrimidine-2-, 4 : 5-dihydrothiazole-2-, 4-methyl - 4 : 5 - dihydrothiazole - 2 -, 5 : 5- di-methyl - 4 : 5 - dihydrothiazole - 2 -, 5 - ethyl - 5 - methyl - 4 : 5 - dihydrothiazole - 2 -, imidazoline-2- and 2 : 4-diketo-1 : 2 : 3 : 4-tetrahydropyrimidine-6-sulphonamides are similarly prepared; (4) 6-acetamido-4-acetoxypyrimidine 2-thiol (prepared from 6-amino-4-hydroxypyrimidine-2-thiol and acetic anhydride in pyridine) is reacted as in (1) to give 6-acetamido-4-hydroxypyrimidine-2-sulphenamide and this is oxidized as in (1) to the corresponding sulphonamide; the 6-propionamido-, 6-valeramido-, 6-caprylamido- and 6-benzamido-compounds are similarly obtained; (5) 5-acetamido-1 : 3 : 4-thiadiazole-2-sulphenamide and the corresponding sulphonamide, and the corresponding 5-propionamido-, 5-valeramido-, 5-caprylamido- and 5-benzamido-compounds are prepared as in (1). Reference is also made to the preparation of sulphonamides from thiols containing other heterocyclic radicals with one, two or more hetero atoms, not reduced or wholly or partly reduced, substituted or unsubstituted, which may be fused with one or more homo or heterocyclic rings. Specific reference is made to isoxazole, pteridine, purine, pyrrole, isoxazoline, pyrrolidine, tetrazole, triazole, pyridine, thiophene, furan, pyran, thiapyran, benzimidazole, naphthothiazole, benzoxazole, quinoline, and pyrido[2 : 1-c-]-s-triazole, in addition to the rings referred to above, to dithiols such as 1 : 2 : 4-thiadiazole-3 : 5- and -2 : 5-dithiols, to alkyl, aryl, aralkyl, alkoxy, carboxamido, halogen, thiono, oxo and hydroxy substituents in the heterocyclic rings and these and nitro groups in the fused-on aromatic rings, to N-alkyl-, N : N-dialkyl-, N-2-aminoethyl-, N-cycloalkyl-, N-alkyl-N-cycloalkyl-, N-2-pyridyl-, N-2-thiazolyl-, N-2-pyrimidyl-, N-phenyl-, N-methyl-N-phenyl-, N-2-thienyl-, N-thenyl-, N-2-furyl-, N-tolyl-, N-benzyl- and N-phenylethyl-sulphonamides and to sulphonamides in which the amide nitrogen forms part of a heterocycle such as piperidine, pyrrolidine, piperazine and morpholine and alkyl substituted derivatives thereof. Specification 377,730, [Group IV], is referred to.ALSO:Heterocyclic sulphenamides wherein the sulphenamide group is attached to a carbon atom of the heterocycle are used as vulcanization accelerators in the compounding and vulcanization of rubber. Specific reference is made to the use of 6-ethoxybenzothiazole-2-sulphenamide, 6-acetamidobenzothiazole-2-sulphenamide, 4-phenyl-5-thiono-4 : 5-dihydro-1 : 3 : 4-thiadiazole-2-sulphenamide and 5-acetamido-1 : 3 : 4-thiadiazole-2-sulphenamide as vulcanization accelerators.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US795174XA | 1954-10-13 | 1954-10-13 |
Publications (1)
Publication Number | Publication Date |
---|---|
GB795174A true GB795174A (en) | 1958-05-21 |
Family
ID=22151064
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB27101/55A Expired GB795174A (en) | 1954-10-13 | 1955-09-22 | Heterocyclic sulphonamides |
Country Status (1)
Country | Link |
---|---|
GB (1) | GB795174A (en) |
Cited By (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3478030A (en) * | 1966-06-27 | 1969-11-11 | Abbott Lab | Benzamide substituted anilino aminopyrimidines |
US3839303A (en) * | 1971-01-18 | 1974-10-01 | Monsanto Co | Inhibiting premature vulcanization with aminothiopyrimidines |
JPS544379B1 (en) * | 1971-01-18 | 1979-03-06 | ||
US4483864A (en) * | 1983-02-04 | 1984-11-20 | University Of Iowa Research Foundation | Non-classical topical treatment for glaucoma |
US4975449A (en) * | 1983-02-04 | 1990-12-04 | University Of Iowa Research Foundation | Topical treatment of glaucoma with 2-benzothiazolesulfonamide derivative |
US5079305A (en) * | 1989-09-05 | 1992-01-07 | Monsanto Company | Rubber compositions comprising sulfenimide accelerators |
US5374689A (en) * | 1992-06-05 | 1994-12-20 | Monsanto Company | Rubber compositions containing 2-pyrazine sulfenamides |
WO2004017964A1 (en) | 2002-08-19 | 2004-03-04 | Pfizer Products Inc. | Combination therapy for hyperproliferative diseases |
US6878703B2 (en) | 2000-11-21 | 2005-04-12 | Sankyo Company, Limited | Pharmaceutical composition |
WO2007062314A2 (en) | 2005-11-23 | 2007-05-31 | Bristol-Myers Squibb Company | Heterocyclic cetp inhibitors |
CN100387584C (en) * | 2005-07-05 | 2008-05-14 | 杭州保灵有限公司 | A kind of preparation method of methazolamide |
WO2008070496A2 (en) | 2006-12-01 | 2008-06-12 | Bristol-Myers Squibb Company | N- ( (3-benzyl) -2, 2- (bis-phenyl) -propan-1-amine derivatives as cetp inhibitors for the treatment of atherosclerosis and cardiovascular diseases |
WO2008089521A1 (en) | 2007-01-25 | 2008-07-31 | Verva Pharmaceuticals Ltd | Insulin sensitisers and methods of treatment |
EP2392567A1 (en) | 2005-10-21 | 2011-12-07 | Bristol-Myers Squibb Company | Benzothiazine derivatives and their use as lxr modulators |
WO2014170786A1 (en) | 2013-04-17 | 2014-10-23 | Pfizer Inc. | N-piperidin-3-ylbenzamide derivatives for treating cardiovascular diseases |
WO2015012205A1 (en) | 2013-07-23 | 2015-01-29 | 第一三共株式会社 | Medicine for preventing or treating hypertension |
WO2016055901A1 (en) | 2014-10-08 | 2016-04-14 | Pfizer Inc. | Substituted amide compounds |
WO2020150473A2 (en) | 2019-01-18 | 2020-07-23 | Dogma Therapeutics, Inc. | Pcsk9 inhibitors and methods of use thereof |
-
1955
- 1955-09-22 GB GB27101/55A patent/GB795174A/en not_active Expired
Cited By (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3478030A (en) * | 1966-06-27 | 1969-11-11 | Abbott Lab | Benzamide substituted anilino aminopyrimidines |
US3839303A (en) * | 1971-01-18 | 1974-10-01 | Monsanto Co | Inhibiting premature vulcanization with aminothiopyrimidines |
JPS544379B1 (en) * | 1971-01-18 | 1979-03-06 | ||
US4483864A (en) * | 1983-02-04 | 1984-11-20 | University Of Iowa Research Foundation | Non-classical topical treatment for glaucoma |
US4636515A (en) * | 1983-02-04 | 1987-01-13 | University Of Iowa Research Foundation | Non-classical topical treatment for glaucoma |
US4975449A (en) * | 1983-02-04 | 1990-12-04 | University Of Iowa Research Foundation | Topical treatment of glaucoma with 2-benzothiazolesulfonamide derivative |
US5079305A (en) * | 1989-09-05 | 1992-01-07 | Monsanto Company | Rubber compositions comprising sulfenimide accelerators |
US5374689A (en) * | 1992-06-05 | 1994-12-20 | Monsanto Company | Rubber compositions containing 2-pyrazine sulfenamides |
US6878703B2 (en) | 2000-11-21 | 2005-04-12 | Sankyo Company, Limited | Pharmaceutical composition |
WO2004017964A1 (en) | 2002-08-19 | 2004-03-04 | Pfizer Products Inc. | Combination therapy for hyperproliferative diseases |
CN100387584C (en) * | 2005-07-05 | 2008-05-14 | 杭州保灵有限公司 | A kind of preparation method of methazolamide |
EP2392567A1 (en) | 2005-10-21 | 2011-12-07 | Bristol-Myers Squibb Company | Benzothiazine derivatives and their use as lxr modulators |
WO2007062314A2 (en) | 2005-11-23 | 2007-05-31 | Bristol-Myers Squibb Company | Heterocyclic cetp inhibitors |
WO2008070496A2 (en) | 2006-12-01 | 2008-06-12 | Bristol-Myers Squibb Company | N- ( (3-benzyl) -2, 2- (bis-phenyl) -propan-1-amine derivatives as cetp inhibitors for the treatment of atherosclerosis and cardiovascular diseases |
WO2008089521A1 (en) | 2007-01-25 | 2008-07-31 | Verva Pharmaceuticals Ltd | Insulin sensitisers and methods of treatment |
WO2014170786A1 (en) | 2013-04-17 | 2014-10-23 | Pfizer Inc. | N-piperidin-3-ylbenzamide derivatives for treating cardiovascular diseases |
WO2015012205A1 (en) | 2013-07-23 | 2015-01-29 | 第一三共株式会社 | Medicine for preventing or treating hypertension |
WO2016055901A1 (en) | 2014-10-08 | 2016-04-14 | Pfizer Inc. | Substituted amide compounds |
WO2020150473A2 (en) | 2019-01-18 | 2020-07-23 | Dogma Therapeutics, Inc. | Pcsk9 inhibitors and methods of use thereof |
EP4470609A2 (en) | 2019-01-18 | 2024-12-04 | Astrazeneca AB | Pcsk9 inhibitors and methods of use thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB795174A (en) | Heterocyclic sulphonamides | |
GB940169A (en) | A process for preventing darkening and precipitates in photographic developers | |
ES384420A1 (en) | Certai 1,2,4-oxa- and -thiadiazol-5-ylthioalkanoic acid derivatives | |
IE37572B1 (en) | 1-aminouracil compounds a process for their production and their use as herbicides | |
GB965009A (en) | New 2,3-dimercapto-quinoxalines | |
US2835670A (en) | Aminoazoledisulfides | |
HUT40118A (en) | Process for preparing 5-/azolyl-oxy-phenyl-carbamoyl/-barbituric acid-derivatives | |
US3265706A (en) | Processes for preparing certain 2-substituted benzimidazole compounds | |
GB1527807A (en) | Thiazolines | |
US3796710A (en) | 1h-2,1,4-benzothiadiazines | |
GB961917A (en) | Process for the production of new 3-hydroxy-benzisoxazoles | |
GB759675A (en) | Improvements in the manufacture of merocyanine dyes | |
GB687760A (en) | Improvements relating to the preparation of heterocyclic sulphonamides | |
JPH0586040A (en) | Process for producing 2-aminodithiothiazole and 2-aminotrithiothiazole | |
YU126483A (en) | Process for obtaining new cephalosporine derivatives | |
GB1412546A (en) | Morpholine derivatives | |
ES387561A1 (en) | 2-acylamino-1,3,4-thiadiazole-(thi)one-(5)compounds and herbicidal compositions | |
GB841419A (en) | Method for the preparation of aminodithiothiazoles | |
GB846573A (en) | ºÔ-substituted benzene sulphonamides and processes for the manufacture thereof | |
Bon et al. | The synthesis of 2-substituted imino-3-amino-4-thiazolidones | |
US2393507A (en) | Composition of matter | |
GB922708A (en) | Production of sulfoxides and sulfones | |
SU520363A1 (en) | Derivatives of 3-thiocarbamylthiomethylbenzthiazolthione-2 as accelerators of sulfur vulcanization of rubber compounds based on general purpose rubbers | |
GB1003784A (en) | Basically substituted derivatives of halogeno-4-azaphenthiazines | |
KR950702565A (en) | Tricyclic cefem sulphones as elastase inhibitors |